Publications of S. C. Azad

Huge, V.; Rammes, G.; Beyer, A.; Zieglgänsberger, W.; Azad, S. C.: Activation of kappa opioid receptors decreases synaptic transmission and inhibits long-term potentiation in the basolateral amygdala of the mouse. European Journal of Pain 13 (2), pp. 124 - 129 (2009)

Azad, S. C.; Kurz, J.; Marsicano, G.; Lutz, B.; Zieglgänsberger, W.; Rammes, G.: Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala. Learning & Memory 15 (3), pp. 143 - 152 (2008)

Domenici, M. R.; Azad, S. C.; Marsicano, G.; Schierloh, A.; Wotjak, C. T.; Dodt, H.-U.; Zieglgänsberger, W.; Lutz, B.; Rammes, G.: Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamergic synaptic transmission. The Journal of Neuroscience 26 (21), pp. 5794 - 5799 (2006)

Azad, S. C.; Huge, V.; Schöps, P.; Hilf, C.; Beyer, A.; Dodt, H.-U.; Rammes, G.; Zieglgänsberger, W.: Endogenes Cannabinoidsystem. Einfluss auf neuronale Plastizität und Schmerzgedächtnis. Schmerz 19 (6), pp. 521 - 527 (2005)

Azad, S. C.; Eder, M.; Simon, W.; Hapfelmeier, G.; Dodt, H. U.; Zieglgänsberger, W.; Rammes, G.: The potassium channel modulator flupirtine shifts the frequency-response function of hippocampal synapses to favour LTD in mice. Neuroscience Letters 370 (2-3), pp. 186 - 190 (2004)

Azad, S. C.; Monory, K.; Marsicano, G.; Cravatt, B. F.; Lutz, B.; Zieglgänsberger, W.; Rammes, G.: Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling. Journal of Neuroscience 24 (44), pp. 9953 - 9961 (2004)

Marsicano, G.; Goodenough, S.; Monory, K.; Hermann, H.; Eder, M.; Cannich, A.; Azad, S. C.; Cascio, M. G.; Ortega Gutierrez, S.; van der Stelt, M. et al.; Lopez-Rodriguez, M. L.; Casanova, E.; Schütz, G.; Zieglgänsberger, W.; Di Marzo, V.; Behl, C.; Lutz, B.: CB 1 Cannabinoid Receptors and On-Demand Defense against Excitotoxicity. Science 302 (5642), pp. 84 - 88 (2003)

Azad, S. C.: Endocannabinoids, a novel target in pain treatment. Journal of Neurochemistry 85 (Suppl. Suppl. 2), p. 12 - 12 (2003)

DeBock, F.; Kurz, J.; Azad, S. C.; Parsons, C. G.; Hapfelmeier, G.; Zieglgänsberger, W.; Rammes, G.: alpha(2)-Adrenoreceptor activation inhibits LTP and LTD in the basolateral amygdala: involvement of G(i/o)-protein-mediated modulation of Ca2+-channels and inwardly rectifying K+-channels in LTD. European Journal of Neuroscience 17 (7), pp. 1411 - 1424 (2003)

Azad, S. C.; Eder, M.; Marsicano, G.; Lutz, B.; Zieglgänsberger, W.; Rammes, G.: Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse. Learning & Memory 10 (2), pp. 116 - 128 (2003)

Azad, S. C.: Sind Cannabinoide eine effektive und sichere Option bei der Schmerzbehandlung? Schmerz 17 (1), pp. 63 - 65 (2003)

Azad, S. C.; Zieglgänsberger, W.: Was wissen wir über die Chronifizierung von Schmerz? Der Schmerz 17, pp. 441 - 444 (2003)

Eder, M.; Becker, K.; Rammes, G.; Schierloh, A.; Azad, S. C.; Zieglgänsberger, W.; Dodt, H.-U.: Distribution and properties of functional postsynaptic kainate receptors on neocortical layer V pyramidal neurons. The Journal of Neuroscience 23 (16), pp. 6660 - 6670 (2003)

Azad, S. C.; Marsicano, G.; Eberlein, I.; Putzke, J.; Zieglgänsberger, W.; Spanagel, R.; Lutz, B.: Differential role of the nitric oxide pathway on Δ⁹-THC-induced central nervous system effects in the mouse. European Journal of Neuroscience 13, pp. 561 - 568 (2001)